CD49d is a disease progression biomarker and a potential target for immunotherapy in Duchenne muscular dystrophy

BACKGROUND: Duchenne muscular dystrophy (DMD) is caused by mutations in the dystrophin gene. The immune inflammatory response also contributes to disease progression in DMD patients. In a previous study, we demonstrated higher levels of circulating CD49dhi and CD49ehi T cells in DMD patients compare...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Skelet Muscle
Main Authors: Pinto-Mariz, Fernanda, Rodrigues Carvalho, Luciana, Prufer De Queiroz Campos Araujo, Alexandra, De Mello, Wallace, Gonçalves Ribeiro, Márcia, Cunha, Maria Do Carmo Soares Alves, Cabello, Pedro Hernan, Riederer, Ingo, Negroni, Elisa, Desguerre, Isabelle, Veras, Mariana, Yada, Erica, Allenbach, Yves, Benveniste, Olivier, Voit, Thomas, Mouly, Vincent, Silva-Barbosa, Suse Dayse, Butler-Browne, Gillian, Savino, Wilson
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2015
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4674917/
https://ncbi.nlm.nih.gov/pubmed/26664665
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13395-015-0066-2
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados